1. Infants born to mothers who used medications for treatment of attention-deficit/hyperactivity disorder (ADHD) during pregnancy had increased risk of central nervous system (CNS) disorders, prematurity, and admission to the neonatal intensive care unit (NICU). 2. ADHD medication use during pregnancy was not associated with increased risk of neonatal mortality or congenital malformations. Evidence Level: … Continue reading ADHD medications in pregnancy may increase risk of infantile morbidity